Results for tag: "Pimavanserin"

Pimavanserin is a drug used to treat schizophrenia, a mental disorder characterized by abnormal social behavior and difficulty in distinguishing between reality and imagination. It is a selective serotonin inverse agonist, meaning it works by blocking serotonin receptors in the brain. Pimavanserin is approved by the US Food and Drug Administration (FDA) for the treatment of schizophrenia in adults. It is also being studied for its potential to treat other psychiatric disorders, such as bipolar disorder and depression. Pimavanserin is a relatively new drug in the schizophrenia market, but it has been gaining traction in recent years. It is generally well-tolerated and has fewer side effects than other antipsychotic medications. It is also available in both oral and injectable forms, making it more accessible to patients. Companies in the Pimavanserin market include Acadia Pharmaceuticals, which manufactures and markets the drug, as well as other pharmaceutical companies that are researching and developing new treatments for schizophrenia. Other companies in the market include Otsuka Pharmaceuticals, Lundbeck, and Sunovion Pharmaceuticals. Show Less Read more